Accueil / Nouvelles et Évènements
Prix
GlycoNet Investigator received McGill’s Principal’s Prize for Public Engagement Through Media
From offering policy advice to sharing his expertise on COVID-19 with the media and public, Dr. Donald Sheppard is recognized a role model with his achievement in engaging with the broader community
GlycoNet and BridgeBio Pharma Inc. initiate collaboration to discover potential treatments for genetic diseases through glycomics research
Genetic disease research has benefitted substantially from the study of glycomics, which relates to the functions of glycans, or sugar, in biological systems
GlycoNet researchers discover how a plaque-fighting protein protects against Alzheimer’s
Research highlights potential pathway for new treatments for neurodegenerative diseases
More stories
- Tout
- Prix
- Communauté
- Profil du Réseau
- Communiqué de presse
- Points saillants de la recherche
GlycoNet Investigator featured in “100 Lives of Insulin” project
Dr. Mike Riddell has spent his career looking at ways to make diabetes easier and safer for those who are living with it. He talks about the why and how behind it.
Canadian Glycomics Network launches Call for Proposals for glycomics projects to address fundamental health challenges in Canada
The Network will commit $1.8 million in glycomics to support made-in-Canada health innovations and build a sustainable national bioeconomy
Canadian company blazes a new trail to drug development
A prime example of Canada’s success in the sub‑sector of the life sciences industry is 48Hour Discovery
Funding research toward treating the root cause of neurodegenerative disease
Professor and GlycoNet Investigator Simonetta Sipione’s research awarded major grant from the Canadian Institutes of Health Research
New radiotracers could be key for new treatments and early detection for Parkinson’s
Nuclear medicine researcher and GlycoNet Investigator Chris Phenix from the University of Saskatchewan has been awarded US$150,000 by The Michael J. Fox Foundation to develop diagnostic radiotracers for early detection of Parkinson’s Disease
Limiting the spread of tuberculosis
GlycoNet researchers are identifying effective ways to prevent one of the top 10 causes of death worldwide
GlycoNet-affiliated start-up 48Hour Discovery and Merck initiate drug discovery project
Project funded through CQDM Quantum Leap program with support from Merck and GlycoNet will exploit new drug development platform
GlycoNet joins BioTalent Canada’s partnership network
Partnership will improve the career prospects in the biotechnology and life sciences sectors in Canada
GlycoNet Investigator named the inaugural recipient of The Legge Orr MI4 Leadership Award
The $1 million donation supports the leadership of Dr. Don Sheppard, Director of McGill Interdisciplinary Initiative in Infection and Immunity (MI4), and will help drive the institute’s mission forward
Réseau Canadien de la Glycomique
E5-33 Gunning/Lemieux Chemistry Centre
University of Alberta, T6G 2G2
Tél.: 780-492-6204
Téléc.: 780-492-4147
© Réseau Canadien de la Glycomique (GlycoNet). Tous droits réservés.
French 
English